Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Kolditz

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
The Journal of Antimicrobial Chemotherapy|February 17, 2009
Medical management of pulmonary actinomycosis: data from 49 consecutive casesMartin Kolditz, Jakob Bickhardt, Wolfgang Matthiessen, et al.
Infection|June 27, 2024
Epidemiology and risk factors of community-acquired pneumonia in patients with different causes of immunosuppressionFabian Reichel, Falko Tesch, Saskia Berger, et al.
European Journal of Internal Medicine|April 23, 2025
Burden and risk factors for 30-day readmission and mortality after CAP hospitalization: A population-based cohort studyFabian Reichel, Falko Tesch, Saskia Berger, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 2, 2014
Haemoptysis due to pulmonary venous stenosisSilke Braun, Ivan Platzek, Klaus Zöphel, et al.
Onkologie|June 5, 2010
Intimal pulmonary artery sarcoma presenting as severe dyspnea and right heart insufficiencyMichael Halank, Christiane Jakob, Martin Kolditz, et al.
Infection|May 6, 2026
The role of cancer and immunosuppression in pneumocystis pneumonia: a large comprehensive population-based studyFabian Reichel, Falko Tesch, Saskia Berger, et al.
Journal of Medical Virology|April 13, 2026
Effectiveness of Remdesivir on All-Cause In-Hospital Mortality in Patients With Chronic Respiratory Comorbidities Who Are Hospitalized With COVID-19 in the United StatesVeronika Müller, Martin Kolditz, Valentina Shvachko, et al.
Texas Heart Institute Journal|March 14, 2012
Prolactin and its 16-kDa N-terminal fragment: are higher in patients with precapillary pulmonary hypertension than in a healthy control groupUta Hönicke, Steffen Albrecht, Hagen Schrötter, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 9, 2022
Early post-discharge mortality in CAP: frequency, risk factors and a prediction toolVerena Glöckner, Mathias W Pletz, Gernot Rohde, et al.
Infection|November 20, 2023
Validation of risk scores for prediction of severe pneumonia in kidney transplant recipients hospitalized with community-acquired pneumoniaMoritz Müller-Plathe, Bilgin Osmanodja, Georg Barthel, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
The Journal of Antimicrobial Chemotherapy|February 17, 2009
Medical management of pulmonary actinomycosis: data from 49 consecutive casesMartin Kolditz, Jakob Bickhardt, Wolfgang Matthiessen, et al.
Infection|June 27, 2024
Epidemiology and risk factors of community-acquired pneumonia in patients with different causes of immunosuppressionFabian Reichel, Falko Tesch, Saskia Berger, et al.
European Journal of Internal Medicine|April 23, 2025
Burden and risk factors for 30-day readmission and mortality after CAP hospitalization: A population-based cohort studyFabian Reichel, Falko Tesch, Saskia Berger, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 2, 2014
Haemoptysis due to pulmonary venous stenosisSilke Braun, Ivan Platzek, Klaus Zöphel, et al.
Onkologie|June 5, 2010
Intimal pulmonary artery sarcoma presenting as severe dyspnea and right heart insufficiencyMichael Halank, Christiane Jakob, Martin Kolditz, et al.
Infection|May 6, 2026
The role of cancer and immunosuppression in pneumocystis pneumonia: a large comprehensive population-based studyFabian Reichel, Falko Tesch, Saskia Berger, et al.
Journal of Medical Virology|April 13, 2026
Effectiveness of Remdesivir on All-Cause In-Hospital Mortality in Patients With Chronic Respiratory Comorbidities Who Are Hospitalized With COVID-19 in the United StatesVeronika Müller, Martin Kolditz, Valentina Shvachko, et al.
Texas Heart Institute Journal|March 14, 2012
Prolactin and its 16-kDa N-terminal fragment: are higher in patients with precapillary pulmonary hypertension than in a healthy control groupUta Hönicke, Steffen Albrecht, Hagen Schrötter, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 9, 2022
Early post-discharge mortality in CAP: frequency, risk factors and a prediction toolVerena Glöckner, Mathias W Pletz, Gernot Rohde, et al.
Infection|November 20, 2023
Validation of risk scores for prediction of severe pneumonia in kidney transplant recipients hospitalized with community-acquired pneumoniaMoritz Müller-Plathe, Bilgin Osmanodja, Georg Barthel, et al.
Pageof 7